日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy

利用 HLA II 类限制性 TCR 靶向端粒酶进行癌症免疫治疗

Pierre Dillard, Hakan Köksal, Solrun Melkorka Maggadottir, Anna Winge-Main, Sylvie Pollmann, Mathilde Menard, Marit Renée Myhre, Gunhild M Mælandsmo, Vivi Ann Flørenes, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg

Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

暂时性 TCR 重定向 T 细胞用于实体肿瘤免疫治疗的临床前评估

Nadia Mensali, Marit Renée Myhre, Pierre Dillard, Sylvie Pollmann, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, Else Marit Inderberg

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

CD37CAR T细胞疗法治疗B细胞淋巴瘤的临床前开发

Hakan Köksal, Pierre Dillard, Sarah E Josefsson, Solrun Melkorka Maggadottir, Sylvie Pollmann, Anne Fåne, Yngvild Nuvin Blaker, Klaus Beiske, Kanutte Huse, Arne Kolstad, Harald Holte, Gunnar Kvalheim, Erlend B Smeland, June H Myklebust, Else Marit Inderberg, Sébastien Wälchli

Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate

类风湿关节炎中的抗 PAD4 自身抗体:用小分子合成底物测量血清中随时间变化的水平以及对 PAD4 活性的影响

Sylvie Pollmann, Maria Stensland, Eirik Hornes Halvorsen, Ludvig M Sollid, Tore K Kvien, Burkhard Fleckenstein, Oyvind Molberg